CANCER Web Results

What Is Cancer? - NCI Explanations about what cancer is, how cancer cells differ from normal cells, and genetic changes that cause cancer to grow and spread.

Genetic Testing Fact Sheet - NCI - National Cancer Institute A fact sheet about genetic testing for inherited cancer risk. Includes who should consider testing, and how to understand test results.

Why Is Early-Onset Cancer On the Rise? - NCI There is some evidence that inherited cancer-related genetic changes, often called germline mutations, may bear some responsibility for the growing number of early-onset cancers, according to Zsofia Stadler, Ph.D., of Memorial Sloan Kettering Cancer Center (MSKCC).

NIH study investigates trends in early-onset cancers - NCI Changes in cancer screening guidelines, advances in imaging technologies, and increased surveillance of high-risk individuals may also have led to earlier cancer diagnoses, potentially contributing to rising rates among younger age groups.

Impacts of prevention, screening, treatment on cancer deaths For more information about cancer, please visit the NCI website at cancer.gov or call NCI’s contact center, the Cancer Information Service, at 1-800-4-CANCER (1-800-422-6237).

CTEP Home Page - NCI - Cancer Learn more about NCI’s Cancer Therapy Evaluation Program (CTEP) resources for cancer research, clinical trial protocol development and clinical trial operations resources.

Home - CTSU The NCI's Cancer Information Service can answer general cancer-related questions posed by patients, their families, the public, and health care professionals. A qualified medical professional should be consulted for individual treatment advice.

State Cancer Profiles > Quick Profiles Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI.

Shield Blood Test Approved for Colorectal Cancer Screening Developing blood-based cancer screening tests has been an active area of research, with researchers and device companies developing different ways of identifying clues in cell-free DNA that can potentially detect cancer early.

Surveillance, Epidemiology, and End Results Program An authoritative source for cancer statistics in the US. We collect incidence, prevalence and survival data and publish reports on these and cancer mortality. For those interested in cancer statistics and surveillance methods.